Imperial Innovations : Appointment of Joint Broker

4 January 2017

Imperial Innovations Group plc

Appointment of Joint Broker

Imperial Innovations Group plc (AIM: IVO, 'the Group', 'Innovations') has appointed RBC Capital Markets as Joint Broker alongside its existing Nominated Adviser and Joint Broker, J.P. Morgan Cazenove, with immediate effect.

For further information contact:

Imperial Innovations Group plc	020 3053 8834
Russ Cummings, Chief Executive Officer
Jon Davies, Director of Communications
Instinctif Partners	020 7457 2020
Adrian Duffield/Mel Toyne-Sewell/Chantal Woolcock
J.P. Morgan Cazenove (Nominated Adviser)	020 7742 4000
Michael Wentworth-Stanley/Alec Pratt
RBC Capital Markets	020 7653 4000
Darrell Uden / Marcus Jackson / Laura White

About Imperial Innovations -www.imperialinnovations.co.uk

Imperial Innovations Group plc ('Innovations') creates, builds and invests in pioneering technology companies and licensing opportunities developed from outstanding scientific research from the 'Golden Triangle', the geographical region broadly bounded by London, Cambridge and Oxford.

This area has an unrivalled cluster of outstanding academic research and technology businesses, and is home to four of the world's top 10 universities, as well as leading research institutions, the cream of the UK's science and technology businesses and many of its leading investors.

Innovations supports scientists and entrepreneurs in the commercialisation of their ideas, through the licensing of intellectual property, by leading the formation of new companies, by recruiting high-calibre management teams and by providing investment and encouraging co-investment. Innovations remains an active investor over the life of its portfolio companies, with the majority of Innovations' investment going into businesses in which it is already a shareholder.

Since becoming a public company in 2006, Innovations has raised more than £440 million of equity from investors, which has enabled it to invest in some of the most exciting spin-outs to come out of UK academic research. In addition, the Group has agreed £80.0 million in loan facilities from the European Investment Bank (EIB).

Between Innovations' admission to AIM (August 2006) and 31 July 2016, Innovations has invested a total of £306.7 millionacross its portfolio companies, which have raised collectively investment of £1.5 billion.